as900672
Recombinant proteinexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2007 (NCT00505752)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
FSHR agonist
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- as900672
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00553514 | Phase 2 | Dec 1, 2007 | Merck KGaA, University of Valencia |
| NCT00505752 | Phase 2 | Jan 1, 2007 | Merck KGaA, Merck Serono |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck KGaA | For profit | 2 | 2 | 1 | 2007 |
| Merck Serono | For profit | 1 | 0 | 1 | 2007 |
| University of Valencia | Academic/Hospital | 1 | 0 | 1 | 2007 |
3 organizations
Page 1 / 1